Free Research Report as Cigna’s Revenues Grew 9% and Earnings Surged 62%

LONDON, UK / ACCESSWIRE / June 5, 2018 / If you want access to our free earnings report on Cigna Corp. (NYSE: CI), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=CI. The Company reported its financial results on May 03, 2018, for the first quarter of the fiscal year 2018 (Q1 FY18). The global health services organization surpassed market estimates for revenues and earnings for Q1 FY18. Additionally, the Company provided guidance for FY18. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Cigna most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=CI

Earnings Highlights and Summary

For the first quarter of the fiscal year 2018, Cigna’s total revenues improved 9% to $11.4 billion compared to $10.5 billion in the first quarter of the fiscal year 2017, primarily driven by strong business growth in its Commercial Healthcare and Global Supplemental Benefits segments. The Company’s revenue numbers exceeded market expectations of $11.0 billion.

Cigna added earnings from Premiums of $9.0 billion in Q1 FY18 versus $8.2 billion in Q1 FY17, increasing 10.4% on a y-o-y basis. During the reported quarter, the Company’s medical customer base grew by 327,000 lives to 16.2 million customers, led by a growth in the Select, Individual, and Middle Market segments.

For the reported quarter, Cigna posted total benefits and expenses of $10.2 billion compared to $9.6 billion in the prior year’s same quarter.

Cigna reported a net income of $915.0 million in Q1 FY18 compared to $598.0 million in Q1 FY17, increasing 53% on a y-o-y basis. The Company’s adjusted income advanced 40% to $1.0 billion in the reported quarter versus $719.0 million in the prior year’s comparable period.

During Q1 FY18, Cigna’s earnings per share (EPS) soared 62% to $3.72 compared to $2.30 in Q1 FY17. The Company posted adjusted EPS of $4.11 in the reported quarter versus $2.77 in the corresponding quarter of last year, beating market estimates of $3.37.

Segment Details

Cigna operates through four reportable segments, namely (i) Global Health Care; (ii) Global Supplemental Benefits; (iii) Group Disability and Life; and (iv) Corporate & Other Operations.

For Q1 FY18, Cigna’s Global Health Care segment aggregated operating revenues of $9.09 billion compared to $8.3 billion in Q1 FY17, primarily due to a customer growth in its Commercial Risk business. The segment’s adjusted income from operations grew 43% to $871.0 million in the reported quarter compared to $610.0 million in the year ago same period.

During the first quarter of the fiscal year 2018, Cigna’s Global Supplemental Benefit segment generated operating revenues of $1.1 billion, up 21% from $909.0 million in the first quarter of the fiscal year 2017. The segment’s adjusted operating income advanced 51% to $112.0 million in the reported quarter versus $74.0 million in the year ago comparable period, reflecting business growth and strong operating expenses management.

Cigna’s Group Disability and Life segment’s revenues marginally declined to $1.1 billion in Q1 FY18. The segment’s adjusted operating income decreased to $67.0 million in the reported quarter compared to $68.0 million in the year ago corresponding period, mainly due to an increase in life insurance claims.

For the reported quarter, Cigna had a loss of $40.0 million from its Corporate & Other Operations segment compared to a loss of $33.0 million in the year ago same period.

Cash Matters

As of March 31, 2018, Cigna’s cash and cash equivalents stood at $2.8 billion compared to $4.2 billion as of March 31, 2017. During the reported quarter, the Company generated net cash inflows from operating activities of $2.0 billion versus $1.6 billion in the comparable quarter of last year.

As of May 02, 2018, Cigna had repurchased 1.3 million shares of its common stock for approximately $275.0 million.

Outlook

For FY18, Cigna expects total adjusted income from operations to be in the range of $3.17 billion to $3.27 billion, representing a growth of 7% to 8%. The Company anticipates adjusted EPS to be in the band $12.85 to $13.25 for FY18, improving from the previous guidance of $12.40 and $12.90. The Company estimates medical customer growth to be in the range of 400,000 to 500,000 customers for FY18.

Stock Performance Snapshot

June 04, 2018 – At Monday’s closing bell, Cigna’s stock marginally rose 0.11%, ending the trading session at $171.00.

Volume traded for the day: 1.01 million shares.

Stock performance in the past twelve-month period – up 3.98%

After yesterday’s close, Cigna’s market cap was at $41.25 billion.

Price to Earnings (P/E) ratio was at 15.43.

The stock has a dividend yield of 0.02%.

The stock is part of the Healthcare sector, categorized under the Health Care Plans industry. This sector was up 0.3% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501739